Regency Centers is a preeminent national owner, operator, and developer of shopping centers located in suburban trade areas with compelling demographics. Our portfolio includes thriving properties merchandised with highly productive grocers, restaurants, service providers, and best-in-class retailers that connect to their neighborhoods, communities, and customers. Operating as a fully integrated real estate company, Regency Centers is a qualified real estate investment trust (REIT) that is self-administered, self-managed, and an S&P 500 Index member.

Regency Centers Corporation

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Regeneron (REGN) and Merck & Company (MRK) with bull...

Analysts Are Bullish on These Healthcare Stocks: Regeneron (REGN), Merck & Company (MRK)

Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals has completed a mid-stage clinical...

Regeneron’s REGN7544 Trial Reaches Key Milestone in Sepsis-Induced Hypotension

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BioMarin Pharmaceutical (BMRN) and Regeneron (REGN...

Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN) and Regeneron (REGN)

The latest update is out from Regency Centers ( ($REG) ). On May 18, 2026, Regency Centers Corporation released an updated investor presentation fo...

Regency Centers Updates Investor Presentation for Conferences

An announcement from Regency Centers ( ($REG) ) is now available. On May 18, 2026, Regency Centers Corporation released an updated investor present...

RemeGen Co. Ltd. Class H ( ($HK:9995) ) just unveiled an update. RemeGen Co., Ltd. has proposed amendments to its articles of association to reflec...

RemeGen Plans Governance and Articles Overhaul Following Share Incentive Issuances

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Veracyte (VCYT), Tonix Pharma (TNXP) and Regeneron...

Analysts Offer Insights on Healthcare Companies: Veracyte (VCYT), Tonix Pharma (TNXP) and Regeneron (REGN)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Regeneron (REGN) and Korro Bio (KRRO) with bullish s...

Analysts Are Bullish on These Healthcare Stocks: Regeneron (REGN), Korro Bio (KRRO)

Citi analyst Geoff Meacham downgraded Regeneron to a Hold yesterday and set a price target of $700.00. According to TipRanks, Meacham is a 5-star a...

Citi downgrades Regeneron (REGN) to a Hold

Last week, stocks pulled back from record highs as oil, yields, and rate fears returned to the forefront. The S&P 500 (SPX) ended at 7,408.50, down...

The Week That Was, The Week Ahead: Macro and Markets, May 17

Regeneron Pharmaceuticals ($REGN), Sanofi ($SNYNF) announced an update on their ongoing clinical study. The study, called “A Prospective, Observati...

Real-World Dupixent Data in Canada: What Regeneron and Sanofi Investors Should Watch

RemeGen Co. Ltd. Class H ( ($HK:9995) ) has shared an announcement. RemeGen Co., Ltd. has approved a cash management plan allowing the use of up to...

RemeGen Deploys Idle Cash Into RMB453 Million HTSC Wealth Products

Traders seeking the top stock market stories for Tuesday will find them in our roundup.


Morning News Wrap-Up, 5/12/26: Today’s Biggest Stock Market Stories!

Smart Powerr Corp stock was up after the company said it would work to regain listing compliance.


Why Is Smart Powerr Corp Stock (CREG) Up Today?

Regency Centers ( ($REG) ) has issued an announcement. On May 7, 2026, Regency Centers held its annual shareholder meeting, where investors elected...

Regency Centers Shareholders Back Board, Executive Pay Plans

Regency Centers ( ($REG) ) has issued an update. Regency Centers Corporation, a U.S. shopping-center focused REIT listed on NASDAQ under the ticker...

Regency Centers Shareholders Approve Board, Pay, and Auditor

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Geron (GERN), Regeneron (REGN) and TScan Therapeutic...

Analysts Are Bullish on These Healthcare Stocks: Geron (GERN), Regeneron (REGN)

BMO Capital analyst Evan Seigerman maintained a Buy rating on Regeneron today and set a price target of $900.00. Seigerman covers the Healthcare se...

Regeneron (REGN) Receives a Buy from BMO Capital

Citi analyst Geoff Meacham maintained a Buy rating on Regeneron today and set a price target of $900.00. According to TipRanks, Meacham is a 5-star...

Citi Reaffirms Their Buy Rating on Regeneron (REGN)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Regeneron (REGN), Bausch + Lomb Corporation (BLCO) and Indivior (...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Regeneron (REGN), Bausch + Lomb Corporation (BLCO) and Indivior (INDV)

Regency Centers ( ($REG) ) has provided an announcement. Regency Centers reported first-quarter 2026 net income attributable to common shareholders...

Regency Centers Delivers Strong Q1 Results and Outlook

The latest announcement is out from Regency Centers ( ($REG) ). Regency Centers reported solid first-quarter 2026 results on April 29, with net inc...

Regency Centers Reports Strong Q1 2026 Earnings and Outlook

Here’s a quick look at today’s key earnings reports from major publicly traded companies. Investors will be watching closely for updates on financi...

These Are the Stocks Reporting Earnings Today – April 29, 2026

An update from Regis Healthcare Ltd. ( ($AU:REG) ) is now available. Regis Healthcare has announced the appointment of Andrew Kinkade as its new Ma...

Regis Healthcare appoints Andrew Kinkade as new CEO to drive growth and transformation

RemeGen Co. Ltd. Class H ( ($HK:9995) ) has provided an announcement. RemeGen Co., Ltd. has released its unaudited 2026 first quarterly report, pre...

RemeGen Issues Unaudited 2026 First-Quarter Report and Cautions Investors

In a report released on April 23, Steven Wheen from Jarden maintained a Buy rating on Regis Healthcare Ltd., with a price target of A$8.50. The com...

Jarden Reaffirms Their Buy Rating on Regis Healthcare Ltd. (REG)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Argenx Se (ARGX) and Regeneron (REGN) with bullish s...

Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX) and Regeneron (REGN)

In a report released today, Gregory Renza from Truist Financial maintained a Buy rating on Regeneron, with a price target of $801.00. Renza covers ...

Truist Financial Sticks to Their Buy Rating for Regeneron (REGN)

In a report released today, Louise Chen from Scotiabank maintained a Hold rating on Regeneron, with a price target of $770.00. According to TipRank...

Scotiabank Sticks to Their Hold Rating for Regeneron (REGN)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Merck & Company (MRK) and Regeneron (REGN) with bull...

Analysts’ Top Healthcare Picks: Merck & Company (MRK), Regeneron (REGN)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Jade Biosciences (JBIO), Elevance Health (ELV) and...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	REG	$78.41	+0.09%	122.94K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	REG	$78.41	+0.1%	122.94K
3
4
5
6

REG

REG

Get Regency Centers Corporation Data in Excel

Get Regency Centers Corporation Data in Excel